G. Rivard

Bleeding risks associated with inheritance of the Quebec platelet disorder.

F. Adam, S. Whittaker, N. Heddle, 2004, Blood.

Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.

T. Podor, G. Rivard, M. Pai, 2001, Blood.

Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.

M. Diamandis, J. Blavignac, D. Veljkovic, 2009, Blood.

Manuscript title: Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation Short title: Megakaryocyte uPA in Quebec platelet disorder

M. Diamandis, D. Veljkovic, Catherine P. M. Hayward, 2008 .

Fibrinogen degradation products in patients with the Quebec platelet disorder

G. Rivard, C. Hayward, S. Zheng, 1997, British journal of haematology.

Studies of a second family with the Quebec platelet disorder: evidence that the degradation of the alpha-granule membrane and its soluble contents are not secondary to a defect in targeting proteins to alpha-granules.

G. Rivard, C. Hayward, E. Cramer, 1997, Blood.

Factor V (Quebec): a bleeding diathesis associated with a qualitative platelet Factor V deficiency.

K. Mann, A. Giles, G. Rivard, 1984, The Journal of clinical investigation.